Evolving Systemic Targeted Therapy Strategies in Uveal Melanoma and Implications for Ophthalmic Management: A Review

Clinical and Experimental Ophthalmology - United Kingdom
doi 10.1111/ceo.12688
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

BRD4-targeted Therapy Induces Myc-Independent Cytotoxicity in Gnaq/11-Mutatant Uveal Melanoma Cells

Oncotarget
Oncology
2015English

Mechanisms and Strategies to Overcome Resistance to Molecularly Targeted Therapy for Melanoma

Cancer
Cancer ResearchOncology
2017English

Proton Therapy for Uveal Melanoma in 43 Juvenile Patients

Ophthalmology
Ophthalmology
2014English

Discordancy in BRAF Mutations Among Primary and Metastatic Melanoma Lesions: Clinical Implications for Targeted Therapy

Modern Pathology
Forensic MedicinePathology
2014English

Mitochondria-Targeted Therapy for Metastatic Melanoma

English

Review of Evolving Etiologies, Implications and Treatment Strategies for the Superior Vena Cava Syndrome

SpringerPlus
Multidisciplinary
2016English

Diagnosis and Immunotherapy Strategies for Melanoma: A Review

LOJ Medical Sciences
2018English

Nestin Expression in Primary and Metastatic Uveal Melanoma - Possible Biomarker for High-Risk Uveal Melanoma

Acta Ophthalmologica
MedicineOphthalmology
2018English

A Review and Update on the Ophthalmic Implications for Susac Syndrome

Survey of Ophthalmology
Ophthalmology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy